Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer

Name: Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer
License: Public Domain

Royal Marsden NHS Foundation Trust

ClinicalTrials.gov · Datasets · License: Public Domain

locally advanced gastric adenocarcinoma, msi-h/dmmr gastric cancer, msi-h/dmmr gastroesophageal-junction cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 181779
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.